Shanghai Chengda Tianqing

Shanghai Chengda Tianqing is a key research and development subsidiary of Chia Tai Tianqing Pharmaceutical Group (CTTQ), which is part of the Sino Biopharmaceutical conglomerate. Based in Shanghai, the company focuses on the discovery and development of innovative small molecule drugs and biologics, particularly in the fields of oncology, liver disease, and respiratory health. It serves as a critical innovation hub for its parent company, leveraging advanced R&D facilities to advance a robust pipeline of candidates through clinical development. The company's efforts contribute significantly to CTTQ's leadership position in the Chinese pharmaceutical market, especially in the treatment of hepatitis and various cancers.